Why the study?
While inter-arm blood pressure differences are known to be associated with cardiovascular events, the prognostic implication of inter-leg blood pressure differences has not been well established.
Does increased inter-leg systolic blood pressure difference predict major adverse cardiovascular events in patients undergoing percutaneous coronary intervention?
Does increased inter-leg systolic blood pressure difference predict major adverse cardiovascular events in patients undergoing percutaneous coronary intervention?
Increased inter-leg systolic blood pressure difference is an easily measurable, independent predictor of worse cardiovascular outcomes in patients after PCI.
Inter-leg BP difference was associated with post-PCI MACE; leaves open its utility for risk stratification pending prospective validation.
BACKGROUND: Although the inter-arm blood pressure (BP) difference has been advocated to be associated with cardiovascular events, the implication of inter-leg BP difference has not been well established. This study was conducted to investigate whether inter-arm and -leg BP differences have prognostic value in patients undergoing percutaneous coronary intervention (PCI). METHODS: In this prospective study, we consecutively enrolled 667 patients who underwent PCI. Both arm and leg BPs were measured at the day after PCI. The primary outcome was a major adverse cardiovascular event (MACE) including cardiac death, acute coronary syndrome, coronary revascularization, stroke, and hospitalization for heart failure during the follow-up period. RESULTS: Mean age was 64.0±11.1 years old, and males were predominant (70.5%). During a mean follow-up period of 3.0 years, MACE occurred in 209 (31.3%) patients. The inter-leg systolic BP difference (ILSBPD) was significantly higher in patients with MACE than those without (9.9±12.3 vs. 7.2±7.5 mmHg, P = 0.004). The inter-arm systolic BP difference was not significantly different between patients with and without MACE (P = 0.403). In multivariable Cox regression analysis, increased ILSBPD was independently associated with the development of MACE (per 5 mmHg; hazard ratio, 1.07; 95% confidence interval, 1.01-1.14). The inter-arm systolic BP difference was not associated with MACE in the multivariable analysis. CONCLUSION: Increased ILSBPD was independently associated with worse cardiovascular outcomes after PCI. As ILSBPD is easy to measure, it may be helpful in the risk stratification of patients undergoing PCI.
No takes yet. Share an insight, caveat, or question.
Moon et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: